Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals Market Cap : 3.857B for March 25, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Pfizer Inc. | 155.18B |
| Apellis Pharmaceuticals, Inc. | 2.265B |
| ACADIA Pharmaceuticals, Inc. | 3.753B |
| BioMarin Pharmaceutical, Inc. | 10.69B |
| Corcept Therapeutics, Inc. | 4.305B |
Market Cap Related Metrics
| PE Ratio | 55.40 |
| PS Ratio | 1.319 |
| Price to Free Cash Flow | 17.65 |
| Price | 12.26 |
| Earnings Yield | 1.81% |
| Operating PE Ratio | 9.982 |
| Normalized PE Ratio | 39.47 |